![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() by Staff Writers Beijing (AFP) Oct 25, 2017
More than a third of adults in China suffer from high blood pressure, but only one in 20 are able effectively to manage their condition, according to research published Thursday. Strokes are the leading cause of death in China, accounting for one in five deaths annually, researchers said, with uncontrolled high blood pressure a significant risk factor. But fewer than a quarter of people with hypertension in China take medication and treatment among those who receive it was found to be ineffective or unsuitable. The availability of medication for high blood pressure is patchy across the country and one in 12 primary health-care pharmacies do not stock any anti-hypertensive drugs at all, according to two studies published jointly in The Lancet, a leading medical journal. In addition to problems of access, researchers noted that "despite the availability of low-cost antihypertensive medications, higher-cost medications were more often prescribed". Only a third of sites stocked "high-value" medication, referring to drugs that are both recommended and low-cost. Blood pressure levels in China are increasing "likely because of an ageing population, urbanisation, dietary changes and obesity", Professor Lixin Jiang, from Fuwai Hospital in Beijing, said in response to the study. Some 1.7 million people aged 35-75 were screened in all 31 provinces in mainland China as part of the research, an initiative to improve cardiovascular disease risk factors in China. Prescriptions of anti-hypertensive medications at more than 3,300 primary health care sites were also analysed as part of the China Patient-Centered Evaluative Assessment of Cardiac Events (PEACE) Million Persons Project. "It is simple deficiencies in the country's health system that make a large contribution to the disease burden," said Therese Hesketh of the UCL Institute for Global Health and Xudong Zhou of Zhejiang University School of Public Health, Hangzhou, in a joint commentary for the study. "This situation is worrying, not least because prevention and control of hypertension have been a high priority in China for more than two decades."
![]() Miami (AFP) Oct 18, 2017 Researchers have uncovered widespread evidence of a link between traditional Chinese herbal remedies and liver cancer across Asia, a study said Wednesday. The findings suggest stronger measures are needed to prevent people from consuming chemicals called aristolochic acids (AA), which are derived from the woody vines of the Aristolochia plant family, said the report in the journal Science Tr ... read more Related Links Hospital and Medical News at InternDaily.com
![]()
![]() |
|
The content herein, unless otherwise known to be public domain, are Copyright 1995-2024 - Space Media Network. All websites are published in Australia and are solely subject to Australian law and governed by Fair Use principals for news reporting and research purposes. AFP, UPI and IANS news wire stories are copyright Agence France-Presse, United Press International and Indo-Asia News Service. ESA news reports are copyright European Space Agency. All NASA sourced material is public domain. Additional copyrights may apply in whole or part to other bona fide parties. All articles labeled "by Staff Writers" include reports supplied to Space Media Network by industry news wires, PR agencies, corporate press officers and the like. Such articles are individually curated and edited by Space Media Network staff on the basis of the report's information value to our industry and professional readership. Advertising does not imply endorsement, agreement or approval of any opinions, statements or information provided by Space Media Network on any Web page published or hosted by Space Media Network. General Data Protection Regulation (GDPR) Statement Our advertisers use various cookies and the like to deliver the best ad banner available at one time. All network advertising suppliers have GDPR policies (Legitimate Interest) that conform with EU regulations for data collection. By using our websites you consent to cookie based advertising. If you do not agree with this then you must stop using the websites from May 25, 2018. Privacy Statement. Additional information can be found here at About Us. |